Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous Unfractionated Heparin Following Digital Replantation and Revascularization
NCT04725201Phase 4Recruiting
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- May 2021
- Primary completion
- Mar 2027
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of heparin in traumatic amputation, sponsored by Centre hospitalier de l’Université de Montréal. Started May 2021; status: recruiting.
02
Drugs
heparin
03
Conditions
traumatic amputation
Beyond the preview
Go deeper on NCT04725201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04725201.